The effects of green tea supplementation on cardiovascular risk factors: A systematic review and meta-analysis
- PMID: 36704803
- PMCID: PMC9871939
- DOI: 10.3389/fnut.2022.1084455
The effects of green tea supplementation on cardiovascular risk factors: A systematic review and meta-analysis
Abstract
Purpose: A bulk of observational studies have revealed the protective role of green tea supplementation in cardiovascular diseases. The current systematic review and meta-analysis study aimed to establish the effects of green tea supplementation on cardiovascular risk factors including lipid profile, blood pressure, glycemic control markers and CRP.
Methods: A systematic literature search of randomized clinical trials (RCTs) that investigated the effects of green tea supplementation and cardiovascular risk factors was undertaken in online databases including PubMed/Medline, Scopus, Web of Science, and Embase using a combination of green tea and cardiovascular risk factors search terms. Meta-analyses were carried out using a random-effects model. The I2 index was used to assess the heterogeneity of RCTs.
Results: Among the initial 11,286 studies that were identified from electronic databases search, 55 eligible RCTs with 63 effect sizes were eligible. Results from the random effects meta-analysis showed that GTE supplementation significantly reduced TC (WMD = -7.62; 95% CI: -10.51, -4.73; P = < 0.001), LDL-C (WMD = -5.80; 95% CI: -8.30, -3.30; P = < 0.001), FBS (WMD = -1.67; 95% CI: -2.58, -0.75; P = < 0.001), HbA1c (WMD = -0.15; 95% CI: -0.26, -0.04; P = 0.008), DBP (WMD = -0.87; 95% CI: -1.45, -0.29; P = 0.003), while increasing HDL-C (WMD = 1.85; 95% CI: 0.87, 2.84; P = 0.010). Subgroup analyses based on the duration of supplementation (≥ 12 vs. < 12 weeks), dose of green tea extract (GTE) (≥1,000 vs. < 1,000 mg/d), sex (male, female, and both), baseline serum levels of lipid profile, and glycemic control factors demonstrated different results for some risk factors.
Conclusion: The current study suggests improvements in the lipid and glycemic profiles following green tea supplementation. These findings support previous evidence showing the health benefits of green tea supplementation on cardiometabolic risk factors.
Keywords: blood pressure; cardiovascular risk factors; glycemic control; green tea supplementation; lipid profile; meta-analysis; systematic review.
Copyright © 2023 Zamani, Kelishadi, Ashtary-Larky, Amirani, Goudarzi, Torki, Bagheri, Ghanavati and Asbaghi.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
The Effects of Nano-Curcumin Supplementation on Risk Factors for Cardiovascular Disease: A GRADE-Assessed Systematic Review and Meta-Analysis of Clinical Trials.Antioxidants (Basel). 2021 Jun 24;10(7):1015. doi: 10.3390/antiox10071015. Antioxidants (Basel). 2021. PMID: 34202657 Free PMC article. Review.
-
The effect of l-carnitine supplementation on lipid profile and glycaemic control in adults with cardiovascular risk factors: A systematic review and meta-analysis of randomized controlled clinical trials.Clin Nutr. 2020 Jan;39(1):110-122. doi: 10.1016/j.clnu.2019.01.020. Epub 2019 Feb 22. Clin Nutr. 2020. PMID: 30850271
-
Effect of green tea extract on lipid profile in patients with type 2 diabetes mellitus: A systematic review and meta-analysis.Diabetes Metab Syndr. 2020 Jul-Aug;14(4):293-301. doi: 10.1016/j.dsx.2020.03.018. Epub 2020 Apr 5. Diabetes Metab Syndr. 2020. PMID: 32289742
-
The Effects of Vitamin D Supplementation on Glycemic Control, Lipid Profiles and C-Reactive Protein Among Patients with Cardiovascular Disease: a Systematic Review and Meta-Analysis of Randomized Controlled Trials.Curr Pharm Des. 2019;25(2):201-210. doi: 10.2174/1381612825666190308152943. Curr Pharm Des. 2019. PMID: 30854952
-
Effects of green tea consumption on glycemic control: a systematic review and meta-analysis of randomized controlled trials.Nutr Metab (Lond). 2020 Jul 10;17:56. doi: 10.1186/s12986-020-00469-5. eCollection 2020. Nutr Metab (Lond). 2020. PMID: 32670385 Free PMC article. Review.
Cited by
-
Enhancing the Antioxidant Activity of Tea (Camellia sinensis) Through Common Herbal Infusions.Foods. 2024 Oct 16;13(20):3284. doi: 10.3390/foods13203284. Foods. 2024. PMID: 39456346 Free PMC article.
-
Medicinal Plant Extracts against Cardiometabolic Risk Factors Associated with Obesity: Molecular Mechanisms and Therapeutic Targets.Pharmaceuticals (Basel). 2024 Jul 21;17(7):967. doi: 10.3390/ph17070967. Pharmaceuticals (Basel). 2024. PMID: 39065815 Free PMC article. Review.
-
A Systematic Review and Meta-Analysis to Evaluate the Effects of Chitosan on Obesity Indicators.Food Sci Nutr. 2024 Nov 19;12(12):10030-10048. doi: 10.1002/fsn3.4596. eCollection 2024 Dec. Food Sci Nutr. 2024. PMID: 39723066 Free PMC article. Review.
-
Supplements for Lipid Lowering: What Does the Evidence Show?Curr Cardiol Rep. 2023 Aug;25(8):795-805. doi: 10.1007/s11886-023-01903-9. Epub 2023 Jun 10. Curr Cardiol Rep. 2023. PMID: 37300664 Review.
-
The role of tea in managing cardiovascular risk factors: potential benefits, mechanisms, and interventional strategies.Front Nutr. 2025 Apr 24;12:1530012. doi: 10.3389/fnut.2025.1530012. eCollection 2025. Front Nutr. 2025. PMID: 40342365 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous